Autolus Therapeutics Reports Preliminary Second Quarter 2026 Net Product Revenue and Announces Credit Facility of up to $250 Million with Perceptive Advisors

Go back to Autolus Therapeutics Reports Preliminary Second Quarter 2026 Net Product Revenue and Announces Credit Facility of up to $250 Million with Perceptive Advisors
(NASDAQ: AUTL) Delayed: 1.94 +0.02 (1.04%)
Previous Close $1.92    52 Week High
Open $1.92    52 Week Low
Day High $1.95    P/E N/A 
Day Low $1.88    EPS
Volume 1,769,613